{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:20:11Z","timestamp":1790706011793,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para Ci\u00eancia e Tecnologia (FCT)","award":["SFRH\/BPD\/64265\/2009"],"award-info":[{"award-number":["SFRH\/BPD\/64265\/2009"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ejmech.2015.09.007","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T18:34:29Z","timestamp":1441996469000},"page":"438-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Converting maslinic acid into an effective inhibitor of acylcholinesterases"],"prefix":"10.1016","volume":"103","author":[{"given":"Stefan","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Loesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Dias","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Sommerwerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immo","family":"Serbian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianka","family":"Siewert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Pianowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Csuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.09.007_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12272-013-0036-3","article-title":"A\u00a0review on cholinesterase inhibitors for Alzheimer's disease","volume":"36","author":"Anand","year":"2013","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejmech.2015.09.007_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","article-title":"Alzheimer's disease","volume":"377","author":"Ballard","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2015.09.007_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2015.09.007_bib4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","article-title":"Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein","volume":"333","author":"Polvikoski","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2015.09.007_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0022-510X(70)90063-8","article-title":"Observations on the brains of demented old people","volume":"11","author":"Tomlinson","year":"1970","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ejmech.2015.09.007_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0197-4580(92)90027-U","article-title":"Identification of normal and pathological aging in prospectively studied nondemented elderly humans","volume":"13","author":"Dickson","year":"1992","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejmech.2015.09.007_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jalz.2010.04.006","article-title":"Alzheimer's disease, a multifactorial disorder seeking multitherapies","volume":"6","author":"Iqbal","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ejmech.2015.09.007_bib8","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of A\u03b2 immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejmech.2015.09.007_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-010-0705-y","article-title":"Reduction of aggregated Tau in neuronal processes but not in the cell bodies after A\u03b242 immunisation in Alzheimer's disease","volume":"120","author":"Boche","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2015.09.007_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-\u03b2 load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"Rinne","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2015.09.007_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S104161021200052X","article-title":"Brain aging and late-onset Alzheimer's disease: many open questions","volume":"24","author":"Behl","year":"2012","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.ejmech.2015.09.007_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2174\/1874609811003010046","article-title":"Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches","volume":"3","author":"Galimberti","year":"2010","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.ejmech.2015.09.007_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.bcp.2014.01.002","article-title":"Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles","volume":"88","author":"Iqbal","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.09.007_bib14","first-page":"759","article-title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2015.09.007_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2015.09.007_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2015.09.007_bib17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","article-title":"Alzheimer's disease: a disorder of cortical cholinergic innervation","volume":"219","author":"Coyle","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2015.09.007_bib18","series-title":"Cholinesterases and Cholinesterase Inhibitors","first-page":"181","author":"Giacobini","year":"2000"},{"key":"10.1016\/j.ejmech.2015.09.007_bib19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neurosci"},{"key":"10.1016\/j.ejmech.2015.09.007_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/156720512799015127","article-title":"Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex","volume":"9","author":"Ciro","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejmech.2015.09.007_bib21","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide inrodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2015.09.007_bib22","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.3390\/molecules171113439","article-title":"New triterpenes from Maytenus robusta: structural elucidation based on NMR experimental data and theoretical calculations","volume":"17","author":"Sousa","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2015.09.007_bib23","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1016\/j.bmcl.2011.04.042","article-title":"Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum","volume":"21","author":"Lee","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.007_bib24","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/10286020.2012.733702","article-title":"Cholinesterase inhibitory constituents from Ficus bengalensis","volume":"14","author":"Riaz","year":"2012","journal-title":"J.\u00a0Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2015.09.007_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF02969392","article-title":"New butyrylcholinesterase inhibitory triterpenes from Salvia santolinifolia","volume":"29","author":"Mehmood","year":"2006","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejmech.2015.09.007_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1016-8478(23)17016-6","article-title":"Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase","volume":"11","author":"Chung","year":"2001","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ejmech.2015.09.007_bib27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/14786419.2012.734820","article-title":"Bioactive constituents of Salvia chrysophylla Stapf","volume":"27","author":"\u00c7ulhaoglu","year":"2013","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2015.09.007_bib28","first-page":"693","article-title":"A\u00a0novel isopimarane diterpenoid with acetylcholinesterase inhibitory activity from Nepeta sorgerae, an endemic species to the Nemrut mountain","volume":"7","author":"Yilmaz","year":"2012","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.ejmech.2015.09.007_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02980046","article-title":"Acetylcholinesterase inhibitors from the twigs of Vaccinium oldhami Miquel","volume":"27","author":"Lee","year":"2004","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejmech.2015.09.007_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phymed.2012.09.005","article-title":"Lancemaside A isolated from Codonopsis lanceolata and its metabolite echinocystic acid ameliorate scopolamine-induced memory and learning deficits in mice","volume":"20","author":"Jung","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2015.09.007_bib31","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1016\/j.bmc.2014.04.046","article-title":"Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases","volume":"22","author":"Schwarz","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.007_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.canlet.2008.07.033","article-title":"Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway","volume":"273","author":"Reyes-Zurita","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2015.09.007_bib33","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/jn\/136.10.2553","article-title":"Olive fruit extracts inhibit proliferation and induce apoptosis in HT-29 human colon cancer cells","volume":"136","author":"Juan","year":"2006","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.ejmech.2015.09.007_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1476-4598-9-73","article-title":"Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor alpha by inhibiting NF-kappaB signaling pathway","volume":"9","author":"Li","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2015.09.007_bib35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bmc.2008.12.041","article-title":"Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides","volume":"17","author":"Parra","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.007_bib36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bmc.2013.10.047","article-title":"Towards cytotoxic and selective derivatives of maslinic acid","volume":"22","author":"Siewert","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.007_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2013.10.016","article-title":"Esters and amides of maslinic acid trigger apoptosis in human tumor cells and alter their mode of action with respect to the substitution pattern at C-28","volume":"70","author":"Siewert","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.007_bib38","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1016\/j.tetlet.2014.07.074","article-title":"Convenient and chromatography-free partial synthesis of maslinic acid and augustic acid","volume":"55","author":"Sommerwerk","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2015.09.007_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejmech.2014.08.051","article-title":"Sulfamates of methyl triterpenoates are effective and competitive inhibitors of carbonic anhydrase II","volume":"86","author":"Schwarz","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.09.007_bib40","unstructured":"GOLD, Version 5.2; Cambridge Crystallographic Data Centre: Cambridge, U.K.; www.ccdc.cam.ac.uk\/products\/gold_suite."},{"key":"10.1016\/j.ejmech.2015.09.007_bib41","series-title":"MOE, Molecular Operating Environment","year":"2013"},{"key":"10.1016\/j.ejmech.2015.09.007_bib42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J.\u00a0Natl. Cancer Inst."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415302518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415302518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T02:26:49Z","timestamp":1718072809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415302518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":42,"alternative-id":["S0223523415302518"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.09.007","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Converting maslinic acid into an effective inhibitor of acylcholinesterases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}